59 related articles for article (PubMed ID: 2228827)
41. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Jacobs MR; Spangler SK; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295
[TBL] [Abstract][Full Text] [Related]
42. Antibiotic susceptibility of anaerobic bacteria in Europe.
Tunér K; Nord CE
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S387-9. PubMed ID: 8324153
[TBL] [Abstract][Full Text] [Related]
43. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Parker RH; Eggleston M
Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of resistance in anaerobes and new developments in testing.
Finegold SM
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):117S-120S. PubMed ID: 2686914
[TBL] [Abstract][Full Text] [Related]
45. Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infections.
Neu HC
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):896-904. PubMed ID: 2189913
[TBL] [Abstract][Full Text] [Related]
46. Antibiotic use in the emergency department. III. The quinolones, new beta lactams, beta lactam combination agents, and miscellaneous antibiotics.
Schmidt J; Pollack CV
J Emerg Med; 1996; 14(4):483-96. PubMed ID: 8842923
[TBL] [Abstract][Full Text] [Related]
47. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.
Johnson CC
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S371-6. PubMed ID: 8324150
[TBL] [Abstract][Full Text] [Related]
49. Newer beta-lactam agents and the Bacteroides fragilis group.
Cuchural GJ
Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
[TBL] [Abstract][Full Text] [Related]
50. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.
Rolinson GN
J Chemother; 1994 Oct; 6(5):283-318. PubMed ID: 7861195
[TBL] [Abstract][Full Text] [Related]
51. In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.
Brook I
Rev Infect Dis; 1991; 13(6):1170-80. PubMed ID: 1775850
[TBL] [Abstract][Full Text] [Related]
52. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
Fang H; Edlund C; Hedberg M; Nord CE
Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
